Live Surgery: Retroperitoneal Robotic Partial Nephrectomy Left Side
Live Surgery: Retroperitoneal Robotic Partial Nephrectomy Left Side
Dr. James Porter is the most experienced surgeon using the da Vinci robotic system in the Pacific Northwest.Website: http://jamesporterrobotics.com
Phone: (206) 386-6266.
Dr. Porter is currently the medical director for robotic surgery at Swedish Medical Center in Seattle, where he also directs the Robotic and Laparoscopic Fellowship in Urology. In addition, he serves as Director of Robotics for Providence Health and Services. Before joining the Swedish Urology Group, he served as chief of urology at Harborview Medical Center in Seattle and subsequently as head of laparoscopic and robotic surgery in the Department of Urology at the University of Washington Medical Center. Dr. Porter has completed more than 3000 procedures using the robotic da Vinci System, making him one of the top five practitioners in the nation. He specializes primarily in prostate, kidney cancer procedures, and urinary constructive procedures. He also performs urinary constructive procedures and retroperitoneal lymph node dissection for the treatment of testicular cancer.
This surgery was recorded as part of the Challenges in Laparoscopy and Robotics Conference in Leipzig, Germany. Special thank you to Fondazione Vincenzo Pansadoro (https://www.youtube.com/channel/UCV8nnGEFbnUG94jfdzNG-Tw/featured).
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.